Predicting poorer health outcomes in older community-dwelling patients with multimorbidity: prospective cohort study assessing the accuracy of different multimorbidity definitions. Issue 1 (4th January 2019)

• Record Type: Journal Article
• Authors: Sasseville, Maxime; Smith, Susan M; Freyne, Lisa; McDowell, Ronald; Boland, Fiona; Fortin, Martin; Wallace, Emma
• Is Part Of: BMJ open. Volume 9:Issue 1(2019)
• Publication Date: 2019-01-04
• Subjects: multimorbidity -- risk prediction -- chronic diseases -- medications -- polypharmacy; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2018-023919
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Purpose: Multimorbidity is commonly defined and measured using condition counts. The UK National Institute for Health Care Excellence Guidelines for Multimorbidity suggest that a medication-orientated approach could be used to identify those in need of a multimorbidity approach to management. Objectives: To compare the accuracy of medication-based and diagnosis-based multimorbidity measures at higher cut-points to identify older community-dwelling patients who are at risk of poorer health outcomes. Design: A secondary analysis of a prospective cohort study with a 2-year follow-up (2010–2012). Setting: 15 general practices in Ireland. Participants: 904 older community-dwelling patients. Exposure: Baseline multimorbidity measurements based on both medication classes count (MCC) and chronic disease count (CDC). Outcomes: Mortality, self-reported health related quality of life, mental health and physical functioning at follow-up. Analysis: Sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV) adjusting for clustering by practice for each outcome using both definitions. Results: Of the 904 baseline participants, 53 died during follow-up and 673 patients completed the follow-up questionnaire. At baseline, 223 patients had 3 or more chronic conditions and 89 patients were prescribed 10 or more medication classes. Sensitivity was low for both MCC and CDC measures for all outcomes. For specificity, MCC was better for all outcomes with estimates varying from 88.8% (95% CI 85.2% to 91.6%) for physical functioning to 90.9% (95% CI 86.2% to 94.1%) for self-reported health-related quality of life. There were no differences between MCC and CDC in terms of PPV and NPV for any outcomes. Conclusions: Neither measure demonstrated high sensitivity. However, MCC using a definition of 10 or more regular medication classes to define multimorbidity had higher specificity for predicting poorer health outcomes. While having limitations, this definition could be used for proactive identification of patients who may benefit from targeted clinical care.